Angel Biotechnology will be attending the forthcoming
BioEurope conference and partnering event in Dusseldorf,
Germany (6-8th November). If you are interested in learning
Angel Biotechnology Holdings plc, (AIM: ABH) the
biopharmaceutical contract manufacturer, is pleased to announce
a Sales and Marketing agreement for North America with Nigel
At the EGM held earlier today, Angel shareholders voted in
favour of resolutions to give the directors authorities to
allot Ordinary Shares of 0.1p nominal value to an